Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
| USA Pulses
95% CI, 4.7 to 1.6
If state courts move quickly toward trial, NAION verdicts could emerge before federal gastroparesis cases conclude, potentially influencing settlement dynamics across all GLP-1 litigation
To summarize several meta-analyses of CVOTs conducted with GLP-1RAs, it isconfirmed that based on 43 trials, GLP-1RAs are a class of efficacious agent for reducing MACE (MH-OR 0.87 [0.83, 0.92]), cardiovascular and all-cause mortality (MH-OR 0.89 [0.83, 0.96]) [48]
Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats
US$ 21.18
US$ 26.75
US$ 26.84
US$ 26.64
